CN Patent
CN113788817A — 一种尼罗替尼半盐酸盐一水合物晶型及其制备方法
Assigned to Nanjing Hairun Pharmaceutical Co ltd · Expires 2021-12-14 · 4y expired
What this patent protects
本发明属于药物化学领域,具体涉及一种尼罗替尼半盐酸盐一水合物晶型及其制备方法,通过对该晶型的溶解度、吸湿性、稳定性等性能进行考察,结果显示,该晶型溶解性好,吸湿性小,稳定性佳,作为原料药符合制剂产品的生产需要。
USPTO Abstract
本发明属于药物化学领域,具体涉及一种尼罗替尼半盐酸盐一水合物晶型及其制备方法,通过对该晶型的溶解度、吸湿性、稳定性等性能进行考察,结果显示,该晶型溶解性好,吸湿性小,稳定性佳,作为原料药符合制剂产品的生产需要。
Drugs covered by this patent
- nilotinib-hydrochloride (Nilotinib Hydrochloride) · Jan Beumer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.